![](https://sites.duke.edu/extracvd/files/2019/08/heart-1100-x-400.jpg)
A NURSE-LED INTERVENTION TO EXTEND THE HIV TREATMENT CASCADE FOR CARDIOVASCULAR DISEASE PREVENTION
The EXTRA-CVD study is focused on improving blood pressure and cholesterol treatment for people living with HIV, who are on HIV medication, through a nurse-led intervention.Why is this study being done?
People Living with HIV are at 1.2-2 times higher risk of atherosclerotic cardiovascular disease (ASCVD) compared to uninfected individuals—a risk that persists despite viral suppression on Antiretroviral Therapy (ART). Currently, people living with HIV are sub-optimally treated for high BP and cholesterol, possibly due to low perceived risk for ASCVD or challenges in primary care coordination between HIV specialists and non-HIV providers. This study is being done to extend the HIV treatment cascade for two key cardiovascular disease risk factors—blood pressure and cholesterol—to improve uptake of guideline-based ASCVD prevention therapies.![](https://sites.duke.edu/extracvd/files/2019/07/Study-Design.jpg)